scholarly journals Phase I and pharmacokinetic study of TZT-1027, a novel synthetic dolastatin 10 derivative, administered as a 1-hour intravenous infusion every 3 weeks in patients with advanced refractory cancer

2004 ◽  
Vol 15 (4) ◽  
pp. 671-679 ◽  
Author(s):  
P. Schöffski ◽  
B. Thate ◽  
G. Beutel ◽  
O. Bolte ◽  
D. Otto ◽  
...  
1994 ◽  
Vol 85 (10) ◽  
pp. 1057-1062 ◽  
Author(s):  
Tomohide Tamura ◽  
Yasutsuna Sasaki ◽  
Kenji Eguchi ◽  
Tetsu Shinkai ◽  
Yuichiro Ohe ◽  
...  

2000 ◽  
Vol 46 (4) ◽  
pp. 319-328 ◽  
Author(s):  
Jeffrey G. Supko ◽  
Thomas J. Lynch ◽  
Jeffrey W. Clark ◽  
Robert Fram ◽  
Lee F. Allen ◽  
...  

2005 ◽  
Vol 11 (10) ◽  
pp. 3806-3813 ◽  
Author(s):  
Maja J.A. de Jonge ◽  
Ate van der Gaast ◽  
André S.T. Planting ◽  
Leny van Doorn ◽  
Aletta Lems ◽  
...  

1986 ◽  
Vol 18 (1) ◽  
pp. 33-38 ◽  
Author(s):  
N. Simon Tchekmedyian ◽  
Merrill J. Egorin ◽  
Brian E. Cohen ◽  
Richard S. Kaplan ◽  
Elizabeth Poplin ◽  
...  

1986 ◽  
Vol 18 (3) ◽  
Author(s):  
SophieD. Foss� ◽  
Asbj�rn Flokkmann ◽  
Mona Heier ◽  
Magne Aas ◽  
Brit Moe ◽  
...  

2008 ◽  
Vol 14 (10) ◽  
pp. 3105-3112 ◽  
Author(s):  
Miguel A. Izquierdo ◽  
Angela Bowman ◽  
Margarita García ◽  
Duncan Jodrell ◽  
Marisa Martinez ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document